Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The clinical trial will investigate the effect of different formulations of ARA + 0.4% DHA in infant formula on plasma fatty acid status in healthy 6 months old infants supplemented for 6 months. A 6-month follow on phase will provide additional efficacy (e.g. infection rates, immune markers) and safety information in these 12-18 month old infants.
Critère d'inclusion
- Healthy infants